Claire Verschraegen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer (NCT03798639) | Claire Verschraegen | 2019-01-07 |
Track Claire Verschraegen automatically
Every clearance here is in the API, with alerts when new ones post.